- Description
- Table of Contents
- Request Sample
The Global Migraine Drugs market is expected to reach $6.94 billion by 2026 growing at a CAGR of 17.2% from 2018 to 2026. Migraine is a clinical condition related with painful headaches and other different symptoms for example, nausea, sensitivity to smell, and others. These headaches generally occur on one side of the head and each and every episode of migraine has different duration and intensity. Migraine drugs are utilized in the treatment of headaches related with migraine. Factors for example, rise in female population and surge in awareness among patients related to prevention and treatment are driving the market growth. Though, side effects associated with these drugs are projected to inhibit the growth of the market. By drug type, abortive medicines segment acquired significant growth in the market as they can be taken by self-injection, mouth, skin patch, or nasal spray. These forms of medication are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly. The key vendors mentioned are Abbott, Allergan, AstraZeneca, Bayer, Eli Lilly, Endo International, Ethypharm, GlaxoSmithKline, Impax, Johnson and Johnson, Kowa Pharmaceuticals America, Merck, Pfizer, Teva and Winston Pharmaceuticals. Types Covered: • Abortive Medicines • Preventive medicines • Rizatriptan • Sumatriptan • Zolmitriptan • Ergot Alkaloids • Other Drug Types Drug Classes Covered: • Calcitonin Gene-Related Peptide (CGRP) • Acetylcholine Inhibitors/ Neurotoxins Products Covered: • Therapeutic Class • Treatment Class Route of Administrations Covered: • Injection • Oral • Other Route of Administrations Applications Covered: • Clinics • Hospitals • Household Use • Other Applications End Users Covered: • Retail Pharmacies • Online Pharmacies • Hospitals Based Pharmacies Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Migraine Drugs Market, By Type
5.1 Introduction
5.2 Abortive Medicines
5.3 Preventive medicines
5.4 Rizatriptan
5.5 Sumatriptan
5.6 Zolmitriptan
5.7 Ergot Alkaloids
5.8 Other Drug Types
6 Global Migraine Drugs Market, By Drug Class
6.1 Introduction
6.2 Calcitonin Gene-Related Peptide (CGRP)
6.3 Acetylcholine Inhibitors/ Neurotoxins
7 Global Migraine Drugs Market, By Product
7.1 Introduction
7.2 Therapeutic Class
7.3 Treatment Class
8 Global Migraine Drugs Market, By Route of Administration
8.1 Introduction
8.2 Injection
8.3 Oral
8.4 Other Route of Administrations
9 Global Migraine Drugs Market, By Application
9.1 Introduction
9.2 Clinics
9.3 Hospitals
9.4 Household Use
9.5 Other Applications
10 Global Migraine Drugs Market, By End User
10.1 Introduction
10.2 Retail Pharmacies
10.3 Online Pharmacies
10.4 Hospitals Based Pharmacies
11 Global Migraine Drugs Market, By Geography
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 South America
11.6 Middle East & Africa
12 Strategic Benchmarking
13 Vendors Landscape
13.1 Abbott
13.2 Allergan
13.3 AstraZeneca
13.4 Bayer
13.5 Eli Lilly
13.6 Endo International
13.7 Ethypharm
13.8 GlaxoSmithKline
13.9 Impax
13.10 Johnson and Johnson
13.11 Kowa Pharmaceuticals America
13.12 Merck
13.13 Pfizer
13.14 Teva
13.15 Winston Pharmaceuticals
List of Data Tables
Table 1 Global Migraine Drugs Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Migraine Drugs Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Migraine Drugs Market Outlook, By Abortive Medicines (2016-2026) ($MN)
Table 4 Global Migraine Drugs Market Outlook, By Preventive medicines (2016-2026) ($MN)
Table 5 Global Migraine Drugs Market Outlook, By Rizatriptan (2016-2026) ($MN)
Table 6 Global Migraine Drugs Market Outlook, By Sumatriptan (2016-2026) ($MN)
Table 7 Global Migraine Drugs Market Outlook, By Zolmitriptan (2016-2026) ($MN)
Table 8 Global Migraine Drugs Market Outlook, By Ergot Alkaloids (2016-2026) ($MN)
Table 9 Global Migraine Drugs Market Outlook, By Other Drug Types (2016-2026) ($MN)
Table 10 Global Migraine Drugs Market Outlook, By Drug Class (2016-2026) ($MN)
Table 11 Global Migraine Drugs Market Outlook, By Calcitonin Gene-Related Peptide (CGRP) (2016-2026) ($MN)
Table 12 Global Migraine Drugs Market Outlook, By Acetylcholine Inhibitors/ Neurotoxins (2016-2026) ($MN)
Table 13 Global Migraine Drugs Market Outlook, By Product (2016-2026) ($MN)
Table 14 Global Migraine Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
Table 15 Global Migraine Drugs Market Outlook, By Treatment Class (2016-2026) ($MN)
Table 16 Global Migraine Drugs Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 17 Global Migraine Drugs Market Outlook, By Injection (2016-2026) ($MN)
Table 18 Global Migraine Drugs Market Outlook, By Oral (2016-2026) ($MN)
Table 19 Global Migraine Drugs Market Outlook, By Other Route of Administrations (2016-2026) ($MN)
Table 20 Global Migraine Drugs Market Outlook, By Application (2016-2026) ($MN)
Table 21 Global Migraine Drugs Market Outlook, By Clinics (2016-2026) ($MN)
Table 22 Global Migraine Drugs Market Outlook, By Hospitals (2016-2026) ($MN)
Table 23 Global Migraine Drugs Market Outlook, By Household Use (2016-2026) ($MN)
Table 24 Global Migraine Drugs Market Outlook, By Other Applications (2016-2026) ($MN)
Table 25 Global Migraine Drugs Market Outlook, By End User (2016-2026) ($MN)
Table 26 Global Migraine Drugs Market Outlook, By Retail Pharmacies (2016-2026) ($MN)
Table 27 Global Migraine Drugs Market Outlook, By Online Pharmacies (2016-2026) ($MN)
Table 28 Global Migraine Drugs Market Outlook, By Hospitals Based Pharmacies (2016-2026) ($MN)
Table 29 North America Migraine Drugs Market Outlook, By Type (2016-2026) ($MN)
Table 30 North America Migraine Drugs Market Outlook, By Drug Class (2016-2026) ($MN)
Table 31 North America Migraine Drugs Market Outlook, By Product (2016-2026) ($MN)
Table 32 North America Migraine Drugs Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 33 North America Migraine Drugs Market Outlook, By Application (2016-2026) ($MN)
Table 34 North America Migraine Drugs Market Outlook, By End User (2016-2026) ($MN)
Table 35 Europe Migraine Drugs Market Outlook, By Type (2016-2026) ($MN)
Table 36 Europe Migraine Drugs Market Outlook, By Drug Class (2016-2026) ($MN)
Table 37 Europe Migraine Drugs Market Outlook, By Product (2016-2026) ($MN)
Table 38 Europe Migraine Drugs Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 39 Europe Migraine Drugs Market Outlook, By Application (2016-2026) ($MN)
Table 40 Europe Migraine Drugs Market Outlook, By End User (2016-2026) ($MN)
Table 41 Asia Pacific Migraine Drugs Market Outlook, By Type (2016-2026) ($MN)
Table 42 Asia Pacific Migraine Drugs Market Outlook, By Drug Class (2016-2026) ($MN)
Table 43 Asia Pacific Migraine Drugs Market Outlook, By Product (2016-2026) ($MN)
Table 44 Asia Pacific Migraine Drugs Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 45 Asia Pacific Migraine Drugs Market Outlook, By Application (2016-2026) ($MN)
Table 46 Asia Pacific Migraine Drugs Market Outlook, By End User (2016-2026) ($MN)
Table 47 South America Migraine Drugs Market Outlook, By Type (2016-2026) ($MN)
Table 48 South America Migraine Drugs Market Outlook, By Drug Class (2016-2026) ($MN)
Table 49 South America Migraine Drugs Market Outlook, By Product (2016-2026) ($MN)
Table 50 South America Migraine Drugs Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 51 South America Migraine Drugs Market Outlook, By Application (2016-2026) ($MN)
Table 52 South America Migraine Drugs Market Outlook, By End User (2016-2026) ($MN)
Table 53 Middle East & Africa Migraine Drugs Market Outlook, By Type (2016-2026) ($MN)
Table 54 Middle East & Africa Migraine Drugs Market Outlook, By Drug Class (2016-2026) ($MN)
Table 55 Middle East & Africa Migraine Drugs Market Outlook, By Product (2016-2026) ($MN)
Table 56 Middle East & Africa Migraine Drugs Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 57 Middle East & Africa Migraine Drugs Market Outlook, By Application (2016-2026) ($MN)
Table 58 Middle East & Africa Migraine Drugs Market Outlook, By End User (2016-2026) ($MN)